Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 3 1

Status

Completed 7Unknown 4Recruiting 2Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4Gynecologic 2

Conditions

Stomach Neoplasms 2Colorectal Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Oxaliplatin 288Capecitabine 218Fluorouracil 212Irinotecan 145Leucovorin 139Gemcitabine 124S 1 (combination) 110apatinib 109Cisplatin 102Drug Therapy 98Bevacizumab 98Radiotherapy 97Paclitaxel 97camrelizumab 89sintilimab 79Cetuximab 75lenvatinib 62Neoadjuvant Therapy 61tislelizumab 55Surgical Procedures, Operative 54Sorafenib 53Folfox protocol 53toripalimab 52Docetaxel 52130-nm albumin-bound paclitaxel 47Laparoscopy 41HMPL-013 40XELOX 39Radiosurgery 36Albumin-Bound Paclitaxel 36

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × Enhanced Recovery After Surgery × Gastrointestinal × Clear all
NCT03160924 2020-05-22

The Impact of Enhanced Recovery After Surgery (ERAS) Program on Clinical and Immunological Outcomes for Minimally-invasive Gastrectomy

Chinese University of Hong Kong

Phase 3 Unknown
50 enrolled
Gastrointestinal

Stomach Neoplasms

NCT03121729 2018-04-30

ERASG1

Jinling Hospital, China

Phase NA Unknown
1,000 enrolled
Gastrointestinal

Stomach Neoplasms

NCT03126058 2018-04-30

ERASC1

Jinling Hospital, China

Phase NA Unknown
1,000 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT02644603 2017-06-27

Effect of Enhanced Recovery After Surgery(ERAS) After Liver Resection for Primary Liver Cancer

Shanghai Zhongshan Hospital

Phase NA Unknown
214 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡